Lipid Care in Maryland
A Closer Look at the Complexity of Lipid Testing
For anyone who’s ever reviewed a lipid panel, terms like LDL, VLDL, IDL, Lp(a), non-HDL, TRP, Apo B, small-LDL, lipoprotein size, and particle number can feel overwhelming. Add obesity, insulin resistance, and metabolic syndrome, and it’s easy to see why many patients—and even clinicians—struggle to make sense of it all.
Published
Categorized as Heart Health, Hypertriglyceridemia, Insights from Dr. Tashko, Insulin Resistance, Lipid Health, Obesity Care
Lomitapide: A Bright Hope for Kids with Homozygous Familial Hypercholesterolemia (HoFH)
Living with homozygous familial hypercholesterolemia (HoFH) can feel overwhelming. This rare genetic condition causes dangerously high LDL cholesterol levels from a young age. For children, it means facing the risk of heart disease or stroke far too early in life. However, lomitapide, a medication originally approved for adults in 2012, is showing promising results for kids with HoFH.
Published
2024 NLA Expert Clinical Consensus on Apoprotein B (Apo B)
Here I summarize the National Lipid Association’s recent expert consensus, which emphasizes apolipoprotein B (Apo B) as a key tool in managing cardiovascular risk. Apo B, present on atherogenic lipoproteins, gives a more precise assessment of cardiovascular risk than traditional LDL cholesterol (LDL-C) measurements.
Published
Why Apo B Matters More Than Cholesterol for Atherosclerosis
ApoB, short for Apolipoprotein B, is becoming an essential tool in understanding and managing atherosclerosis. Traditional cholesterol tests tell us only part of the story about lipid health. ApoB provides a more complete picture by measuring the number of atherogenic, or “bad” particles that lead to heart disease.
Published
Atherosclerosis Made Simple
In the fast-paced world we live in, health can often feel like an afterthought—something we take for granted until a problem arises. But lurking beneath the surface, in the very arteries that sustain our lives, there can be a silent and dangerous condition: atherosclerosis.
Published
Small LDL Particles: The Hidden Menace to Your Heart and How to Measure Them
Small LDL particles are a critical factor in heart health that many people don’t know about. Because they’re small and dense, they can more easily penetrate your artery walls, causing plaque buildup and inflammation. High triglycerides often accompany small LDL particles, creating a dangerous combination that can increase your risk of cardiovascular disease.
Published
Categorized as Heart Health, Insights from Dr. Tashko, Insulin Resistance, Lipid Health, Triglycerides
Atherosclerosis: The Most Common Silent Threat
Imagine your arteries as vital highways, tirelessly transporting oxygen-rich blood to every corner of your body. Now, picture these highways gradually narrowing, obstructed by a buildup of plaque – a sticky, cholesterol-laden substance that threatens to impede the flow of life-sustaining blood. This is the insidious reality of atherosclerosis.
Published
Lp(a): The Hidden Risk Factor for Heart Disease You Need to Know About
Lp(a) is a significant, often underestimated risk factor for cardiovascular disease. Its unique characteristics, driven by the apo(a) protein, make it a potent contributor to atherosclerosis and related complications.
Published